CONTACT US
Events
Events

Meet the Precision
AQ team at ISPOR 2025

Montreal, QC, Canada | May 13-16, 2025

Digital Pharma – 3

Schedule time to meet our HEOR & Access Strategy team at ISPOR 2025 in Montreal, QC, Canada from May 13 – 16, 2025. 

Whether it’s building the right evidence or refining your value story, we’re here to simplify the journey from development to patient care – so your therapies can reach the patients who need them most.  
 
Complete the form to book a meeting, and we’ll reach out to confirm the details.

Meet Our HEOR & Access Strategy Team

AQ_Leadership_LanceGrady AQ_Leadership_LanceGrady_bw

Lance Grady

Executive Vice President, Managing Partner - HEOR & Access Strategy,

Kathy Lang Kathy Lang-B&W

Kathy Lang, PhD

Executive Vice President, Partner
- HEOR & Access Strategy,

Jeroen Jansen Jeroen Jansen-BW

Jeroen Jansen, PhD

Chief Scientist - HEOR,

Ross Maclean Ross Maclean-BW

Ross Maclean, MD

Executive Vice President, Partner
- HEOR & Access Strategy,

Shannon Cope Shannon Cope-BW

Shannon Cope, MSc

Senior Advisor - HEOR,

Eve Jamali Eve Jamali-BW

Eve Jamali, MSc

Senior Vice President, Managing Director – Global Pricing and Access Strategy,

Stephanie Kennedy Stephanie Kennedy-BW

Stephanie Kennedy, PhD

Senior Vice President – Global Pricing and Access Strategy,

Andrew Frederickson-1 Andrew Frederickson-BW

Andrew Frederickson, MS

Vice President - HEOR,

Alicia Pepper-2 Alicia Pepper-BW-1

Alicia Pepper, PhD

Vice President - HEOR,

Shelby Corman-1 Shelby Corman-BW-1

Shelby Corman, PharmD, MS, BCPS

Vice President - HEOR,

Jacki Chou Jacki Chou-BW

Jacki Chou, MPP, MPL

Vice President - HEOR,

Schedule a Meeting

Explore our blog

Finding Lost-to-Follow-Up Patients Through EHR Precision: A Case Study

Finding Lost-to-Follow-Up Patients Through EHR Precision: A Case Study

February 18, 2026

Navigating the New Frontier: How GUARD & GLOBE Will Transform Drug Pricing

Navigating the New Frontier: How GUARD & GLOBE Will Transform Drug Pricing

Jonathan Higginson | VP, US Access Strategy

February 16, 2026

2028 and Beyond: Winning JCA in Rare Diseases

2028 and Beyond: Winning JCA in Rare Diseases

Jenny Chen, MSc | Senior Director, Precision AQ Emma Hawe, MSc | Senior Vice President, Managing Director, Precision AQ...

February 10, 2026